Neurogene (NGNE) Assets (2013 - 2026)
Neurogene (NGNE) recorded Assets of $244.36 million in Q2 2026, down 17.8% from $297.32 million a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene reported Assets of $288.6 million, down 14.0% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Across earlier years, Assets came in at $335.73 million in FY2024 (+50.8%), $222.57 million in FY2023 (+103.7%), $109.27 million in FY2022 (-33.1%) and $163.26 million in FY2021 (-22.4%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2024.
- On a year-over-year basis, Assets has declined for three consecutive quarters, with growth averaging 36.0% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 103.7% in Q4 2023, against a decline of 34.0% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $263.14 million (Q1 2026), $288.6 million (Q4 2025) and $287.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Neurogene | 642.28 Mn | 642.28 Mn | - | 244.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244.36 Mn |
| Mar 31, 2026 | 263.14 Mn |
| Dec 31, 2025 | 288.60 Mn |
| Sep 30, 2025 | 287.83 Mn |
| Jun 30, 2025 | 297.32 Mn |
| Mar 31, 2025 | 315.30 Mn |
| Dec 31, 2024 | 335.73 Mn |
| Sep 30, 2024 | 164.12 Mn |
| Jun 30, 2024 | 179.82 Mn |
| Mar 31, 2024 | 195.35 Mn |
| Dec 31, 2023 | 222.57 Mn |
| Sep 30, 2023 | 89.59 Mn |
| Jun 30, 2023 | 94.01 Mn |
| Mar 31, 2023 | 98.46 Mn |
| Dec 31, 2022 | 109.27 Mn |
| Sep 30, 2022 | 126.58 Mn |
| Jun 30, 2022 | 137.02 Mn |
| Mar 31, 2022 | 149.13 Mn |
| Dec 31, 2021 | 163.26 Mn |
| Sep 30, 2021 | 175.93 Mn |
API Access
Neurogene Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();